Fielder Capital Group LLC Takes Position in McKesson Co. (NYSE:MCK)

Fielder Capital Group LLC acquired a new position in shares of McKesson Co. (NYSE:MCK) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 511 shares of the company’s stock, valued at approximately $237,000.

Several other institutional investors have also recently added to or reduced their stakes in MCK. Addison Advisors LLC boosted its position in shares of McKesson by 7.9% during the fourth quarter. Addison Advisors LLC now owns 299 shares of the company’s stock worth $138,000 after buying an additional 22 shares during the period. Keystone Financial Services increased its stake in McKesson by 2.1% during the fourth quarter. Keystone Financial Services now owns 1,192 shares of the company’s stock worth $552,000 after purchasing an additional 24 shares during the period. Austin Private Wealth LLC lifted its position in shares of McKesson by 2.5% during the fourth quarter. Austin Private Wealth LLC now owns 1,094 shares of the company’s stock worth $506,000 after purchasing an additional 27 shares in the last quarter. Quent Capital LLC boosted its stake in shares of McKesson by 2.2% in the fourth quarter. Quent Capital LLC now owns 1,240 shares of the company’s stock valued at $574,000 after purchasing an additional 27 shares during the period. Finally, Kanawha Capital Management LLC boosted its stake in shares of McKesson by 4.7% in the fourth quarter. Kanawha Capital Management LLC now owns 607 shares of the company’s stock valued at $281,000 after purchasing an additional 27 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Stock Performance

NYSE:MCK traded up $4.55 during mid-day trading on Monday, hitting $533.41. 634,119 shares of the company’s stock traded hands, compared to its average volume of 702,469. McKesson Co. has a 1 year low of $364.08 and a 1 year high of $544.81. The company has a market cap of $70.10 billion, a PE ratio of 24.17, a price-to-earnings-growth ratio of 1.41 and a beta of 0.45. The firm’s 50 day simple moving average is $530.66 and its 200 day simple moving average is $493.16.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 7th. The company reported $7.74 EPS for the quarter, beating analysts’ consensus estimates of $7.05 by $0.69. The firm had revenue of $80.90 billion for the quarter, compared to analysts’ expectations of $77.93 billion. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. McKesson’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.90 EPS. On average, research analysts expect that McKesson Co. will post 27.59 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be paid a $0.62 dividend. This represents a $2.48 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date is Friday, May 31st. McKesson’s payout ratio is 11.24%.

Insider Buying and Selling at McKesson

In related news, EVP Leann B. Smith sold 186 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the transaction, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at approximately $749,456. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other McKesson news, EVP Leann B. Smith sold 186 shares of the business’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total transaction of $92,256.00. Following the transaction, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Brian S. Tyler sold 3,473 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the completion of the transaction, the chief executive officer now owns 43,445 shares of the company’s stock, valued at approximately $22,789,074.75. The disclosure for this sale can be found here. 0.21% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

MCK has been the topic of a number of research reports. SVB Leerink started coverage on shares of McKesson in a report on Monday, February 26th. They set an “outperform” rating and a $600.00 target price on the stock. Morgan Stanley lifted their target price on McKesson from $522.00 to $548.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Argus upped their price target on McKesson from $510.00 to $570.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Leerink Partnrs reiterated an “outperform” rating on shares of McKesson in a research note on Monday, February 26th. Finally, StockNews.com upgraded shares of McKesson from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Two analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $536.71.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.